Abstract:Purpose of review: The optimal revascularization strategy for coronary artery disease depends on various factors, such as disease complexity, patient characteristics, and preferences. Including a heart team in complex cases is crucial to ensure optimal outcomes. Decision-making between percutaneous coronary intervention and coronary artery bypass grafting must consider each patient's clinical profile and coronary anatomy. While current practice guidelines offer some insight into the optimal revascularization approach for the various phenotypes of coronary artery disease, the evidence to support either strategy continues to evolve and grow. Given the large amount of contemporary data on revascularization, this review aims to comprehensively summarize the literature on coronary artery bypass grafting and percutaneous coronary intervention in patients across the spectrum of coronary artery disease phenotypes. Recent findings: Contemporary evidence suggests that for patients with triple vessel disease, coronary artery bypass grafting is preferred over percutaneous coronary intervention due to better long-term outcomes, including lower rates of death, myocardial infarction, and target vessel revascularization. Similarly, for patients with left main coronary artery disease, both percutaneous coronary intervention and coronary artery bypass grafting can be considered, as they have shown similar efficacy in terms of major adverse cardiac events, but there may be a slightly higher risk of death with percutaneous coronary intervention. For proximal left anterior descending artery disease, both percutaneous coronary intervention and coronary artery bypass grafting are viable options, but coronary artery bypass grafting has shown lower rates of repeat revascularization and better relief from angina. The Synergy Between PCI with Taxus and Cardiac Surgery score can help in decision-making by predicting the risk of adverse events and guiding the choice between percutaneous coronary intervention and coronary artery bypass grafting. European and American guidelines both agree with including a heart team that can develop and lay out individualized, optimal treatment options with respect for patient preferences. The debate between coronary artery bypass grafting versus percutaneous coronary intervention in multiple different scenarios will continue to develop as technology and techniques improve for both procedures. Risk factors, pre, peri, and post-procedural complications involved in both revascularization strategies will continue to be mitigated to optimize outcomes for those patients for which coronary artery bypass grafting or percutaneous coronary intervention provide ultimate benefit. Methods to avoid unnecessary revascularization continue to develop as well as percutaneous technology that may allow patients to avoid surgical intervention when possible. With such changes, revascularization guidelines for specific patient populations may change in the coming years, which can serve as a limitation of this time-dated review.

Evidence for the ontogenic precedence of suppressor T cell functions in the human neonate

Complete Revascularization Versus Culprit-Only Revascularization in ST-segment Elevation Myocardial Infarction and Multivessel Disease Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis and Trial Sequential Analysis

[Coronary revascularization: clinical features and indications]

The Current State of Coronary Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Interventions

Concepts and Misconceptions

In-hospital and long-term clinical outcomes of spontaneous coronary artery dissection (SCAD): a meta-analysis of conservative versus revascularization approaches

A new ultra wideband tapered balun for improved ELEVEN antenna

Current Landscape and Future Directions of Coronary Revascularization in Ischemic Systolic Heart Failure: A Review

Coronary artery bypass grafting in acute coronary syndromes: modern indications and approaches

Acute coronary syndrome revascularization strategies with multi-vessel coronary artery disease

Formulation and pilot scale production of low-trans vanaspati with modified polyunsaturated fatty acids content

Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure

Percutaneous coronary revascularization versus medical therapy in chronic coronary syndromes: An updated meta‐analysis of randomized controlled trials

Microtiter hemagglutination-inhibition test for the detection of encephalomyocarditis virus antibodies.

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Prevention of Sudden Cardiac Death after Revascularization for Coronary Heart Disease

Role of percutaneous coronary intervention in the modern-day management of chronic coronary syndrome

Uptake of [3H]taurine into medium-size neurons and into identified striatonigral neurons in the rat neostriatum

ISCHEMIA trial. The relationship between medical and interventional approach to stable ischemic heart disease treatment. Myocardial ischemia with non-obstructive coronary arteries (INOCA)

Teaching Image Processing and Visualization Principles to Medicine Students

CMOS Phased Array Transceiver Technology for 60 GHz Wireless Applications